LOXO
Loxo Oncology, Inc
LOXO
LOXO
Delisted
LOXO was delisted on the 14th of February, 2019.
72 hedge funds and large institutions have $543M invested in Loxo Oncology, Inc in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-1
Holders Change %
-1.37%
% of All Funds
1.92%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
8
Increased
34
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Victory Capital Management
San Antonio,
Texas
|
$42.2M |
| 2 |
PC
2
Paulson & Co
New York
|
$19.3M |
| 3 |
3
Wellington Management Group
Boston,
Massachusetts
|
$41.9M |
| 4 |
OM
4
Opaleye Management
Boston,
Massachusetts
|
$2.88M |
| 5 |
AG
5
Artal Group
Luxembourg
|
$1.96M |
Top Sellers
| 1 |
NMC
1
NEA Management Company
Timonium,
Maryland
|
$33.8M |
| 2 |
O
2
OrbiMed
New York
|
$45.2M |
| 3 |
EI
3
EAM Investors
Solana Beach,
California
|
$2.23M |
| 4 |
4
Axa
Paris,
France
|
$5.21M |
| 5 |
5
Ameriprise
Minneapolis,
Minnesota
|
$0 |
